Parkinson’s disease (PD) is characterized by lack of A9 Regorafenib (BAY 73-4506) dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). connections (GxE) in the pathogenesis of PD. Furthermore using small-molecule high-throughput testing we recognize the MEF2C-PGC1α pathway being a healing target to fight PD. INTRODUCTION ARHGDIB Preliminary electric motor symptoms in Parkinson’s disease… Continue reading Parkinson’s disease (PD) is characterized by lack of A9 Regorafenib (BAY